The University of Chicago Header Logo

Loren Joseph

Concepts (375)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Molecular Diagnostic Techniques
3
2020
73
1.220
Why?
Colonic Neoplasms
18
2020
573
1.170
Why?
Pathology, Molecular
4
2017
34
0.980
Why?
ErbB Receptors
9
2017
501
0.630
Why?
Pancreatic Cyst
1
2017
28
0.600
Why?
Telomere
1
2017
114
0.560
Why?
Genetic Diseases, Inborn
1
2016
101
0.520
Why?
Gene Expression Regulation, Neoplastic
13
2020
1266
0.510
Why?
Real-Time Polymerase Chain Reaction
4
2014
282
0.490
Why?
Pancreatic Neoplasms
2
2017
673
0.470
Why?
Fusion Proteins, bcr-abl
1
2013
108
0.440
Why?
Transcription, Genetic
5
2013
1157
0.430
Why?
Neoplasms
3
2016
3041
0.390
Why?
Colitis
4
2020
244
0.370
Why?
Genes, ras
7
2019
98
0.370
Why?
MicroRNAs
4
2020
552
0.350
Why?
Genetic Variation
1
2016
1374
0.330
Why?
Precancerous Conditions
5
2012
200
0.320
Why?
Mutation
10
2019
4143
0.310
Why?
Gene Expression Profiling
3
2015
1432
0.260
Why?
Sarcoma, Myeloid
2
2015
15
0.240
Why?
Proto-Oncogene Proteins
5
2014
666
0.230
Why?
High-Throughput Nucleotide Sequencing
3
2016
482
0.220
Why?
Cyclooxygenase 2
6
2009
99
0.220
Why?
Prognosis
5
2016
3787
0.210
Why?
Humans
39
2020
89367
0.200
Why?
DNA Mutational Analysis
4
2016
529
0.190
Why?
Azoxymethane
7
2011
84
0.190
Why?
Cord Blood Stem Cell Transplantation
2
2013
91
0.190
Why?
Ursodeoxycholic Acid
3
2008
25
0.180
Why?
ras Proteins
4
2014
130
0.180
Why?
Transplantation Conditioning
3
2013
374
0.180
Why?
RNA
1
2004
580
0.180
Why?
Leukemia, Myeloid, Acute
2
2019
794
0.180
Why?
Biomarkers, Tumor
3
2016
1552
0.170
Why?
Insurance, Health, Reimbursement
1
2020
60
0.170
Why?
Receptors, CXCR4
2
2016
45
0.170
Why?
Class I Phosphatidylinositol 3-Kinases
2
2017
64
0.170
Why?
Losartan
1
2019
30
0.170
Why?
MAP Kinase Kinase 2
1
2019
15
0.170
Why?
Insurance Coverage
1
2020
120
0.160
Why?
Adenomatous Polyposis Coli Protein
1
2019
41
0.160
Why?
MAP Kinase Kinase 1
1
2019
39
0.160
Why?
DNA-Binding Proteins
5
2013
1242
0.160
Why?
Reproducibility of Results
2
2016
2759
0.160
Why?
DNA Copy Number Variations
2
2016
177
0.150
Why?
Colon
4
2014
510
0.150
Why?
Receptors, Calcitriol
2
2019
130
0.150
Why?
Telomere Homeostasis
1
2017
30
0.150
Why?
Disease Models, Animal
5
2019
2367
0.150
Why?
Hyaluronan Receptors
1
1997
38
0.150
Why?
Proto-Oncogene Proteins c-akt
1
2019
340
0.150
Why?
Telomerase
1
2017
62
0.150
Why?
Vitamin D
1
2019
269
0.140
Why?
ADAM17 Protein
1
2016
9
0.140
Why?
Chemokine CXCL2
1
2016
16
0.140
Why?
Colitis, Ulcerative
3
2013
739
0.140
Why?
Mice
15
2020
11764
0.140
Why?
Asymptomatic Diseases
1
2016
45
0.130
Why?
Adenoma
2
2010
247
0.130
Why?
Microsatellite Instability
1
2016
49
0.130
Why?
PTEN Phosphohydrolase
1
2017
136
0.130
Why?
Tumor Suppressor Protein p53
2
2017
414
0.130
Why?
Carcinoma, Ductal, Breast
1
1997
159
0.130
Why?
Lymphoma, B-Cell
2
2013
106
0.130
Why?
Cell Transformation, Neoplastic
4
2014
447
0.130
Why?
Cholecalciferol
2
2007
35
0.130
Why?
Antigens, Neoplasm
1
1997
332
0.130
Why?
Transcription Factors
6
2014
1654
0.120
Why?
Mitogen-Activated Protein Kinase 7
1
2014
22
0.120
Why?
Proto-Oncogene Proteins p21(ras)
5
2014
164
0.120
Why?
Antineoplastic Agents
3
2017
2415
0.120
Why?
Insulin Receptor Substrate Proteins
1
2014
55
0.120
Why?
Indazoles
1
2015
67
0.120
Why?
Transforming Growth Factor alpha
2
2016
50
0.120
Why?
Receptor Cross-Talk
1
2014
34
0.120
Why?
Iodine Radioisotopes
1
2015
134
0.120
Why?
Cytogenetic Analysis
1
2014
71
0.120
Why?
Incidental Findings
1
2015
98
0.120
Why?
Paraffin Embedding
1
2014
78
0.120
Why?
Microarray Analysis
1
2014
96
0.120
Why?
Imidazoles
1
2015
148
0.120
Why?
Renin-Angiotensin System
1
2014
81
0.120
Why?
Immunohistochemistry
7
2013
1800
0.110
Why?
Oncogene Proteins v-myb
1
2013
3
0.110
Why?
Apoptosis Regulatory Proteins
1
2014
198
0.110
Why?
Animals
21
2020
27380
0.110
Why?
Haplotypes
2
2013
637
0.110
Why?
Radiopharmaceuticals
1
2015
196
0.110
Why?
Cost-Benefit Analysis
1
2016
461
0.110
Why?
Carcinoma, Papillary
1
2015
160
0.110
Why?
Dextran Sulfate
2
2011
68
0.110
Why?
Protein Kinase Inhibitors
2
2017
605
0.110
Why?
Pancreatitis
1
2013
86
0.110
Why?
Mitogen-Activated Protein Kinase Kinases
1
2013
102
0.110
Why?
Lymphoma
2
2012
265
0.110
Why?
Lymphoma, T-Cell
1
2013
55
0.110
Why?
Treatment Outcome
5
2019
8245
0.110
Why?
Down-Regulation
4
2020
520
0.110
Why?
Benzimidazoles
1
2013
111
0.110
Why?
Chromosome Aberrations
1
2014
390
0.100
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2013
173
0.100
Why?
Up-Regulation
5
2020
727
0.100
Why?
Carcinoma, Pancreatic Ductal
1
2013
112
0.100
Why?
Combined Modality Therapy
1
2016
1719
0.100
Why?
Medical Oncology
1
2016
383
0.100
Why?
Proto-Oncogene Proteins c-pim-1
1
2012
10
0.100
Why?
Early Detection of Cancer
1
2016
416
0.100
Why?
Hematopoiesis
1
2013
166
0.100
Why?
Graft vs Host Disease
2
2011
360
0.100
Why?
Delivery of Health Care
1
2016
435
0.100
Why?
Middle Aged
14
2019
25989
0.100
Why?
HIV
1
2011
48
0.100
Why?
Sequence Analysis, DNA
1
2015
866
0.100
Why?
CCAAT-Enhancer-Binding Protein-beta
2
2008
13
0.100
Why?
Stromal Cells
1
2012
151
0.100
Why?
Autoimmune Diseases
1
2013
249
0.100
Why?
Microfluidic Analytical Techniques
1
2011
45
0.100
Why?
Peripheral Blood Stem Cell Transplantation
1
2011
64
0.100
Why?
Male
19
2019
42423
0.100
Why?
Lung Neoplasms
2
2017
2364
0.090
Why?
Proto-Oncogenes
1
2011
61
0.090
Why?
Graft Survival
2
2013
900
0.090
Why?
Curriculum
1
2016
568
0.090
Why?
Inflammation
2
2020
971
0.090
Why?
Viral Load
1
2011
145
0.090
Why?
Clinical Trials as Topic
1
2016
1150
0.090
Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2010
20
0.090
Why?
Genes, Tumor Suppressor
1
2011
160
0.090
Why?
Sensitivity and Specificity
2
2013
2014
0.090
Why?
RNA, Messenger
7
2013
2017
0.090
Why?
Hepacivirus
1
2011
130
0.090
Why?
Aged
11
2019
19175
0.090
Why?
Paxillin
1
2010
59
0.090
Why?
RNA, Viral
1
2011
317
0.090
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2019
2567
0.090
Why?
Thyroid Neoplasms
1
2015
426
0.090
Why?
Nuclear Proteins
1
2014
726
0.090
Why?
Repressor Proteins
1
2013
423
0.090
Why?
Female
17
2019
46222
0.090
Why?
Cyclin D1
3
2007
84
0.090
Why?
Signal Transduction
9
2016
3386
0.090
Why?
Transplantation Chimera
1
2009
81
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2011
887
0.080
Why?
Antibodies, Neoplasm
1
2009
84
0.080
Why?
Genetic Heterogeneity
1
2009
63
0.080
Why?
Adult
11
2019
26625
0.080
Why?
Colonic Polyps
1
2010
132
0.080
Why?
Enzyme Precursors
1
1988
21
0.080
Why?
Cathepsins
1
1988
21
0.080
Why?
Transformation, Genetic
1
1988
41
0.080
Why?
Adenocarcinoma
3
2017
1195
0.080
Why?
Diet
1
2011
442
0.080
Why?
Transcriptome
1
2013
631
0.080
Why?
HSP70 Heat-Shock Proteins
1
2008
115
0.080
Why?
Cell Line, Tumor
4
2016
2558
0.070
Why?
p38 Mitogen-Activated Protein Kinases
1
2008
125
0.070
Why?
Immediate-Early Proteins
3
1994
165
0.070
Why?
Oligonucleotide Array Sequence Analysis
2
2013
695
0.070
Why?
Genetic Predisposition to Disease
1
2016
2340
0.070
Why?
Young Adult
6
2019
6316
0.070
Why?
Neoplasm Proteins
1
2010
540
0.070
Why?
Antibodies, Monoclonal
2
2011
1412
0.070
Why?
Mice, Knockout
3
2019
2001
0.060
Why?
Adenoma, Villous
1
2005
2
0.060
Why?
Polymerase Chain Reaction
2
2004
922
0.060
Why?
Administration, Oral
2
2019
682
0.060
Why?
Colorectal Neoplasms
1
2013
981
0.060
Why?
Phosphatidylinositol 3-Kinases
2
2017
267
0.060
Why?
Transplantation, Homologous
3
2013
995
0.060
Why?
Microsatellite Repeats
1
2005
148
0.060
Why?
Aged, 80 and over
4
2019
6815
0.060
Why?
Apoptosis
3
2019
1717
0.060
Why?
Reference Standards
1
2004
144
0.060
Why?
Transfection
3
2012
911
0.060
Why?
Prostaglandin-Endoperoxide Synthases
1
2003
36
0.060
Why?
Breast Neoplasms
1
1997
3012
0.050
Why?
Proto-Oncogene Proteins c-bcl-6
2
2013
44
0.050
Why?
Hematopoietic Stem Cell Transplantation
1
2009
890
0.050
Why?
Case-Control Studies
3
2013
1862
0.050
Why?
Isoenzymes
1
2003
274
0.050
Why?
Retroviridae
2
2013
79
0.050
Why?
Blotting, Western
3
2011
794
0.050
Why?
Ligands
2
2016
445
0.050
Why?
Mice, Inbred C57BL
3
2019
3219
0.050
Why?
Cadherins
1
2002
163
0.050
Why?
HCT116 Cells
2
2012
155
0.050
Why?
Rats
5
2011
4041
0.050
Why?
DNA Methylation
2
2020
657
0.050
Why?
Karyopherins
1
2020
15
0.050
Why?
Cell Proliferation
2
2019
1653
0.050
Why?
Reference Values
2
2002
661
0.050
Why?
Laboratories, Hospital
1
2020
8
0.050
Why?
Stakeholder Participation
1
2020
22
0.040
Why?
Base Sequence
4
2008
2327
0.040
Why?
Government Regulation
1
2020
49
0.040
Why?
Intestinal Mucosa
3
2013
805
0.040
Why?
Interleukin-1beta
2
2012
82
0.040
Why?
Costs and Cost Analysis
1
2020
153
0.040
Why?
Tumor Cells, Cultured
2
2019
1057
0.040
Why?
Diamines
1
2019
11
0.040
Why?
Angiotensin II Type 1 Receptor Blockers
1
2019
46
0.040
Why?
Pyrimidinones
1
2019
38
0.040
Why?
Mice, Transgenic
2
2013
1574
0.040
Why?
Pyridones
1
2019
56
0.040
Why?
Vitamins
1
2019
83
0.040
Why?
Survival Analysis
2
2012
1534
0.040
Why?
Pyrazoles
1
2019
150
0.040
Why?
Prostatic Neoplasms
1
2009
1769
0.040
Why?
Cyclooxygenase 2 Inhibitors
2
2008
33
0.040
Why?
Mice, Inbred A
2
2007
23
0.040
Why?
Proto-Oncogene Proteins B-raf
2
2010
146
0.040
Why?
Drug Therapy, Combination
1
2019
784
0.040
Why?
Erlotinib Hydrochloride
1
2017
90
0.040
Why?
Medicare
1
2020
425
0.030
Why?
Spiro Compounds
1
2016
26
0.030
Why?
Diet, Western
1
2016
38
0.030
Why?
Quinazolines
2
2008
221
0.030
Why?
Neoplasms, Experimental
2
2011
269
0.030
Why?
Rats, Inbred F344
2
2008
154
0.030
Why?
Clinical Laboratory Techniques
1
2016
76
0.030
Why?
Endothelium, Vascular
1
1998
433
0.030
Why?
In Situ Hybridization
2
2011
313
0.030
Why?
Lymphatic Metastasis
1
1997
502
0.030
Why?
Piperidines
1
2016
166
0.030
Why?
Vascular Endothelial Growth Factor Receptor-3
1
2015
27
0.030
Why?
Drug Screening Assays, Antitumor
1
2015
78
0.030
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2015
85
0.030
Why?
Snail Family Transcription Factors
1
2014
46
0.030
Why?
Antibodies, Monoclonal, Humanized
2
2011
969
0.030
Why?
Gene Amplification
1
2015
134
0.030
Why?
Genetic Counseling
1
2015
101
0.030
Why?
Carcinogenesis
1
2016
211
0.030
Why?
Tissue Fixation
1
2014
40
0.030
Why?
Angiotensin II
1
2014
93
0.030
Why?
Formaldehyde
1
2014
52
0.030
Why?
Radiation Tolerance
1
2015
173
0.030
Why?
Disease-Free Survival
1
2017
1214
0.030
Why?
Smad4 Protein
1
2013
24
0.030
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2015
95
0.030
Why?
Receptors, IgG
1
1994
53
0.030
Why?
Cell Division
2
2007
696
0.030
Why?
Proto-Oncogene Proteins c-kit
1
2013
80
0.030
Why?
Molecular Sequence Data
3
2002
3027
0.030
Why?
Immunoglobulin Isotypes
1
2013
31
0.030
Why?
Pneumococcal Vaccines
1
2013
28
0.030
Why?
Genetic Association Studies
1
2015
294
0.030
Why?
Drug Resistance, Neoplasm
1
2017
618
0.030
Why?
Lymphocyte Subsets
1
2013
66
0.030
Why?
Lymphocyte Count
1
2013
98
0.030
Why?
fms-Like Tyrosine Kinase 3
1
2013
131
0.030
Why?
GTPase-Activating Proteins
1
2013
67
0.030
Why?
Cell Cycle
1
2014
509
0.030
Why?
Bone Marrow
1
2014
445
0.030
Why?
Virus Diseases
1
2013
98
0.030
Why?
DNA, Complementary
1
2013
392
0.030
Why?
Coculture Techniques
1
2012
174
0.030
Why?
Pharmacogenetics
1
2016
443
0.020
Why?
Genetic Markers
1
2013
478
0.020
Why?
Genetic Vectors
1
2013
446
0.020
Why?
Education, Medical, Graduate
1
2016
395
0.020
Why?
Adult Stem Cells
1
2011
29
0.020
Why?
Rotation
1
2011
91
0.020
Why?
Mutagenesis, Insertional
1
2012
112
0.020
Why?
Immunoglobulin G
1
2013
465
0.020
Why?
Genes, Regulator
1
1991
65
0.020
Why?
G1 Phase
1
2011
65
0.020
Why?
Antigens, CD34
1
2011
159
0.020
Why?
Macrophages
1
2014
572
0.020
Why?
Transplantation, Heterologous
1
2012
370
0.020
Why?
Genes, erbB-1
1
2010
16
0.020
Why?
Cetuximab
1
2011
117
0.020
Why?
Chromosomes, Human, Pair 12
1
2010
65
0.020
Why?
Cell Cycle Proteins
1
2013
401
0.020
Why?
Receptors, Antigen, T-Cell
1
2013
394
0.020
Why?
Mucin-6
1
2010
2
0.020
Why?
Genomics
1
2016
762
0.020
Why?
Dilatation, Pathologic
1
2010
55
0.020
Why?
Illinois
1
2011
480
0.020
Why?
Gene Dosage
1
2010
208
0.020
Why?
In Situ Hybridization, Fluorescence
1
2010
354
0.020
Why?
Hyperplasia
1
2010
152
0.020
Why?
Alemtuzumab
1
2009
85
0.020
Why?
Remission Induction
1
2011
740
0.020
Why?
CD3 Complex
1
2009
134
0.020
Why?
Eosinophilia
1
2010
84
0.020
Why?
CpG Islands
1
2010
157
0.020
Why?
Neoplasm Staging
1
2015
2018
0.020
Why?
Diagnosis, Differential
1
2013
1597
0.020
Why?
B-Lymphocytes
1
1994
739
0.020
Why?
Hematologic Neoplasms
1
2013
343
0.020
Why?
Fibroblasts
2
1991
755
0.020
Why?
Point Mutation
1
2009
245
0.020
Why?
Early Growth Response Protein 1
3
1994
56
0.020
Why?
Pilot Projects
1
2011
871
0.020
Why?
Receptors, Androgen
1
2009
123
0.020
Why?
Oncogene Proteins, Fusion
1
2009
133
0.020
Why?
Deoxyribonuclease EcoRI
1
1988
7
0.020
Why?
Cyclin D
1
2008
14
0.020
Why?
DNA Restriction Enzymes
1
1988
97
0.020
Why?
Translocation, Genetic
1
2009
266
0.020
Why?
Tacrolimus
1
2009
369
0.020
Why?
Amino Acid Sequence
2
1991
2062
0.020
Why?
Nucleic Acid Hybridization
1
1988
243
0.020
Why?
Cholic Acid
1
2008
7
0.020
Why?
Transcription Factor AP-1
1
2008
65
0.020
Why?
Cell Line, Transformed
1
1988
155
0.020
Why?
Cyclins
1
2008
83
0.020
Why?
Follow-Up Studies
1
2015
3667
0.020
Why?
STAT3 Transcription Factor
1
2008
85
0.020
Why?
Promoter Regions, Genetic
1
1991
956
0.020
Why?
DNA Primers
1
2008
543
0.020
Why?
Chronic Disease
1
2011
950
0.020
Why?
Carcinoma, Non-Small-Cell Lung
1
2017
1121
0.020
Why?
Chemoprevention
1
2008
92
0.020
Why?
Cross-Sectional Studies
1
2013
1714
0.020
Why?
United States
1
2020
6997
0.020
Why?
Leukemia
1
2009
323
0.020
Why?
Insulin Resistance
1
2009
353
0.020
Why?
Cloning, Molecular
1
1988
646
0.020
Why?
Dietary Supplements
1
2008
125
0.020
Why?
Incidence
1
2011
1596
0.020
Why?
Extracellular Signal-Regulated MAP Kinases
1
2007
123
0.020
Why?
Neoplasm Invasiveness
1
2008
576
0.020
Why?
Biopsy
1
2010
1185
0.020
Why?
Carcinogens
1
2007
111
0.020
Why?
Proto-Oncogene Proteins c-myc
1
2007
126
0.020
Why?
MAP Kinase Signaling System
1
2007
198
0.020
Why?
Polymorphism, Single Nucleotide
1
2015
2401
0.020
Why?
Internship and Residency
1
2016
1046
0.020
Why?
Proliferating Cell Nuclear Antigen
1
2006
67
0.020
Why?
Cell Growth Processes
1
2006
85
0.020
Why?
DNA
2
1991
1308
0.020
Why?
Blood Glucose
1
2009
836
0.020
Why?
Chromosomal Instability
1
2005
19
0.020
Why?
beta Catenin
1
2007
266
0.020
Why?
Rabbits
2
1998
639
0.020
Why?
Anti-Inflammatory Agents
1
2007
345
0.010
Why?
Insulin
1
2009
1146
0.010
Why?
Disease Progression
1
2008
1489
0.010
Why?
Retrospective Studies
1
2017
9058
0.010
Why?
Injections, Intraperitoneal
1
2002
101
0.010
Why?
DNA Repair
1
2005
362
0.010
Why?
Cells, Cultured
1
2008
2884
0.010
Why?
Random Allocation
1
2002
327
0.010
Why?
Biopsy, Needle
1
2002
233
0.010
Why?
Time Factors
1
2009
5339
0.010
Why?
Rats, Sprague-Dawley
1
2003
1237
0.010
Why?
Umbilical Veins
1
1998
46
0.010
Why?
Cell Line
2
1994
2496
0.010
Why?
Tissue Distribution
1
1998
293
0.010
Why?
Cattle
1
1998
376
0.010
Why?
Adolescent
1
2009
9267
0.010
Why?
Muscle, Smooth, Vascular
1
1998
241
0.010
Why?
Aorta, Thoracic
1
1998
168
0.010
Why?
Pulmonary Artery
1
1998
319
0.010
Why?
Protein Biosynthesis
1
1998
389
0.010
Why?
Early Growth Response Protein 2
1
1994
17
0.010
Why?
Cross-Linking Reagents
1
1994
88
0.010
Why?
Tyrosine
1
1994
133
0.010
Why?
Antibodies, Anti-Idiotypic
1
1993
44
0.010
Why?
Receptors, Antigen, B-Cell
1
1994
116
0.010
Why?
Cyclosporine
1
1994
237
0.010
Why?
Calcium
1
1998
1175
0.010
Why?
Phosphoproteins
1
1994
261
0.010
Why?
Methylation
1
1993
268
0.010
Why?
Early Growth Response Protein 3
1
1991
1
0.010
Why?
RNA-Binding Proteins
1
1994
269
0.010
Why?
Zinc Fingers
1
1991
58
0.010
Why?
Mice, Inbred BALB C
1
1994
1088
0.010
Why?
Haplorhini
1
1991
81
0.010
Why?
Phosphorylation
1
1994
1132
0.010
Why?
Lymphocyte Activation
1
1994
751
0.010
Why?
Gene Expression
1
1994
1310
0.010
Why?
Chromosome Mapping
1
1991
1076
0.000
Why?
Joseph's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (375)
Explore
_
Co-Authors (43)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_